This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Phoenix Children's Hospital Selects Allscripts Sunrise Product Suite

CHICAGO, Feb. 21, 2013 /PRNewswire/ -- Phoenix Children's Hospital, ranked as one of U.S. News & World Report's Best Children's Hospitals, has made significant new investments in the Allscripts (NASDAQ: MDRX) Sunrise product suite.

The addition of Sunrise Financial Manager, Sunrise Ambulatory and Allscripts Community Record will enable Phoenix Children's to connect its community with an integrated clinical and financial platform. Allscripts open architecture, integration and agility of its solutions, and care coordination are three of the reasons Phoenix Children's made the expanded commitment to Allscripts.

"Allscripts open platform as a springboard for innovation will offer us the flexibility to develop the clinical initiatives that are important to our pediatric population," said David Higginson, chief information officer, Phoenix Children's Hospital. "Having a single, integrated view of every patient will enable us to provide better patient care for our community."

Chief Medical Information Officer, Dr. Vinay Vaidya, said: "We did not want a garden variety EHR- we wanted an innovative partner to grow with us, one who is interested in focusing on safety, quality and regulatory outcomes specific to the needs of our organization. We found this in Allscripts."

Phoenix Children's Hospital is Arizona's only licensed children's hospital, providing world-class inpatient, outpatient, trauma, emergency and urgent care to children and families in Arizona and throughout the Southwest. As one of the largest children's hospitals in the country with 465 licensed beds, Phoenix Children's provides care across more than 60 pediatric subspecialties.

"Our goal is to help Phoenix Children's Hospital provide excellent and efficient pediatric care," said Paul M. Black, president and chief executive officer, Allscripts. "This expanded commitment will enable Phoenix Children's to leverage its Allscripts deployment and build upon it in an integrated environment."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs